37 Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Middle 2020.12.01 The Lancet Global Health 9, e130-e143 https://doi.org/10.1016/S2214-109X(20)30425-3 21.597 Meta-analysis 37
36 Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Middle 2020.12.01 The Lancet Global Health 9: e144–60 https://doi.org/10.1016/S2214-109X(20)30489-7 21.597 Meta-analysis 36
35 Uveal Melanoma-Associated Cancers Revisited. First 2020.11.30 ESMOOpen 2020;5:e000990 https://doi.org/10.1136/esmoopen-2020-000990 5.329 Original 35
34 Unilateral Retinoblastoma; Natural History and an Age-Based Protocol in 248 Patients. Last 2020.11.13 Eye https://doi.org/10.1038/s41433-020-01275-2 2.455 Original 34
33 Second Primary Malignancies of Eye and Ocular Adnexa after a First Primary Elsewhere in the Body. First 2020.09.01 Graefe’s Archive for Clinical and Experimental Ophthalmology (2021) 259:515–526 https://doi.org/10.1007/s00417-020-04896-1 2.396 Original 33
32 Paediatric Ependymoma; a Single Center Experience from a Developing Country Middle 2020.12.10 Indian J Cancer. https://doi.org/10.4103/ijc.ijc_373_19 1.224 Original 32
31 Association of Brain Cancer with Risk of Suicide. Last 2020.05.01 JAMA Netw Open 2020;3(5):e203862. https://dx.doi.org/10.1001%2Fjamanetworkopen.2020.3862 5.032 Original 31
30 The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. Last 2020.01.23 Pediatr Hematol Oncol. 37(3):198-210 https://doi.org/10.1080/08880018.2019.1710309 1.232 Original 30
29 Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. Middle 2020.01.12 FASEB J 2020;(May 2019):fj.201901202RR https://doi.org/10.1096/fj.201901202rr 4.966 Original 29
28 Anoctamin-4 Is a Bona Fide Ca2+-Dependent Non-Selective Cation Channel. Middle 2019.02.19 Scientific Reports. (2019) 9:2257 https://doi.org/10.1038/s41598-018-37287-y 3.998 Original 28
27 Suicidal Death Within a Year of a Cancer Diagnosis: A Population-Based Study. Last 2019.01.07 Cancer 2019;125:972-979 https://doi.org/10.1002/cncr.31876 5.772 Original 27
26 Prior Malignancy Impact on Survival Outcomes of Glioblastoma Multiforme; Population-Based Study. Last 2018.12.04 Int. j. neurosci. 129(5):447-454 https://doi.org/10.1080/00207454.2018.1538989 2.107 Original 26
25 Incidence of Adrenal Gland Tumor as a Second Primary Malignancy: SEER-Based Study. Last 2018.08.20 Endocr. connect. 7 (10): 1040–48 https://dx.doi.org/10.1530%2FEC-18-0304 3.335 Original 25
24 Survivin Is High in Retinoblastoma, but What Lies Beneath? First 2018.04.13 J AAPOS 22 (6): 482 https://doi.org/10.1016/j.jaapos.2017.02.021 1.339 Letter 24
23 Risk of second malignancies among survivors of pediatric thyroid cancer. Last 2018.02.28 Int J Clin Oncol 23(4):625-633 https://doi.org/10.1007/s10147-018-1256-9 2.879 Original 23
22 The Incidence of Brainstem Primitive Neuroectodermal Tumors of Childhood Based on SEER Data. Last 2018.01.03 Child’s nerv. syst. 34 (3): 431–39 https://dx.doi.org/10.1007%2Fs00381-017-3687-4 1.298 Original 22
21 Neonates with Cancer and Causes of Death; Lessons from 615 Cases in the SEER Databases. First 2017.06.22 Cancer med 6 (7): 1817–26 https://dx.doi.org/10.1002%2Fcam4.1122 3.491 Original 21
20 Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. Last 2017.03.01 J. pediatr. hematol. oncol. 39 (2): 150–52 https://doi.org/10.1097/mph.0000000000000699 1.016 Case Report 20
19 A Multidisciplinary Approach to Improving the Care and Outcomes of Patients with Retinoblastoma at a Pediatric Cancer Hospital in Egypt. Last 2017.01.13 Ophthalmic genet. 38 (4): 345–51 https://doi.org/10.1080/13816810.2016.1227995 1.308 Original 19
18 Incidence of Orbital, Conjunctival and Lacrimal Gland Malignant Tumors in USA from Surveillance, Epidemiology and End Results, 1973-2009 Last 2016.12.18 Int. j. ophthalmol. 9 (12): 1808–13. https://dx.doi.org/10.18240%2Fijo.2016.12.18 1.33 Original 18
17 A Change Roadmap towards Research Paradigm in Low-Resource Countries: Retinoblastoma Model in Egypt. First 2016.04.25 Int. ophthalmol. 37 (1): 111–18 https://doi.org/10.1007/s10792-016-0233-4 1.314 Report 17
16 Clinical Research Recession: Training Needs Perception Among Medical Students. First 2016.02.05 J. cancer educ. 32 (4): 728–33 https://doi.org/10.1007/s13187-016-0995-4 1.576 Original 16
15 Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. Last 2015.10.17 J Egypt Natl Canc Inst 2015;27:195–203 https://doi.org/10.1016/j.jnci.2015.09.002 0 Original 15
14 Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. Middle 2015.12.21 Biopreserv. biobank 14 (1): 9–16 https://doi.org/10.1089/bio.2015.0004 1.906 Report 14
13 High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries. Last 2015 Ophthalmic Genetics 36(3), 287–289 https://doi.org/10.3109/13816810.2015.1016241 1.308 Original 13
12 Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. Last 2015.04.03 Fetal & Pediatric Pathology 34(3), 176–184 https://doi.org/10.3109/15513815.2015.1014951 0.596 Original 12
11 Childhood Ewing Sarcoma of the Orbit. First 2015.08.01 Journal of Pediatric Hematology/Oncology 37(6), 433–437 https://doi.org/10.1097/mph.0000000000000346 1.016 Original 11
10 Bilateral clear cell sarcoma of the kidney. Last 2015.04.28 Journal of the Egyptian National Cancer Institute 27(2), 97–100 https://doi.org/10.1016/j.jnci.2015.03.002 0 Case Report 10
9 Association between quality of clinical trials and human development index in heart failure using JADAD scale. Last 2015.09.06 Principles and Practice of Clinical Research 2(1), 40-46 http://dx.doi.org/10.21801/ppcrj.2015.12.2 0 Original 9
8 Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. Middle 2015.07.01 Journal of Solid Tumors 5(2), 94 https://doi.org/10.5430/jst.v5n2p94 0 Original 8
7 Orbital tumors in USA: Difference in survival patterns. First 2014.07.20 Cancer Epidemiology 38(5), 515–22 https://doi.org/10.1016/j.canep.2014.07.001 2.179 Original 7
6 Clear Cell Sarcoma of the Kidney; Patients’ Characteristics and Improved Outcome in Developing Countries. First 2014.08.31 Pediatric Blood and Cancer 61(12), 2185–2190 https://doi.org/10.1002/pbc.25192 2.355 Original 6
5 What a reference manager can add for a physician in web 2.0 era. First 2014.10.20 The Egyptian Journal of Cardiothoracic Anesthesia 8(2), 55 http://dx.doi.org/10.4103/1687-9090.143253 0 Report 5
4 Integrating Web 2.0 in Clinical Research Education in a Developing Country. Last 2014.01.07 Journal of Cancer Education 29(3), 536–540 https://doi.org/10.1007/s13187-013-0595-5 1.576 Original 4
3 Nanoparticles targeting mechanisms in cancer therapy; great efforts, less implementations. Last 2013.09.11 Therapeutic Delivery 4(9):1197-209 https://doi.org/10.4155/tde.13.75 0 Review 3
2 International Telepharmacy Education: Another Venue to Improve Cancer Care in the Developing World. First 2012.07.01 Telemedicine and e-Health 18(6): 470–474 https://dx.doi.org/10.1089%2Ftmj.2011.0182 3.536 Original 2
1 Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. Middle 2012.08.10 The Chinese-German Journal of Clinical Oncology 8(11), 484–490 https://doi.org/10.1007/s10330-012-1011-z 0 Original 1
37 Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. Middle 2020.12.01 The Lancet Global Health 9, e130-e143 https://doi.org/10.1016/S2214-109X(20)30425-3 21.597 Meta-analysis 37
36 Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Middle 2020.12.01 The Lancet Global Health 9: e144–60 https://doi.org/10.1016/S2214-109X(20)30489-7 21.597 Meta-analysis 36
35 Uveal Melanoma-Associated Cancers Revisited. First 2020.11.30 ESMOOpen 2020;5:e000990 https://doi.org/10.1136/esmoopen-2020-000990 5.329 Original 35